Alpha-synuclein - Wikipedia
Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration - ScienceDirect
alpha-Synuclein Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological
A schematic representation of alpha-synuclein accumulation and... | Download Scientific Diagram
Alpha Synuclein – The Science of Parkinson's
Structural features of the alpha-synuclein monomer. A structure of the... | Download Scientific Diagram
α-synuclein, LRRK2 and their interplay in Parkinson's disease | Future Neurology
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
Parkinson's disease biomarkers based on α‐synuclein - Fayyad - 2019 - Journal of Neurochemistry - Wiley Online Library
Role of Alpha-Synuclein Proteins in Disease
Targeting Alpha-Synuclein in the Gut May Slow Down Parkinson's Disease | IOS Press
Alpha Synuclein Antibody 10842-1-AP | Proteintech
How does alpha-synuclein spread in Parkinson's? | by Lynn Duffy | Parkinson's UK | Medium
Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications
How A53T Alpha Synuclein Can Affect Parkinson's Disease
The Cellular Environment Affects Monomeric α-Synuclein Structure: Trends in Biochemical Sciences
Alpha-synuclein as therapeutic target in Parkinson's disease
IJMS | Free Full-Text | The Role of α-Synuclein Oligomers in Parkinson's Disease | HTML
Modulating membrane binding of α-synuclein as a therapeutic strategy | PNAS
alpha-Synuclein-based Model for Studying Parkinsons Disease Pathology: R&D Systems
Frontiers | Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson's Disease | Aging Neuroscience
Alpha Synuclein in Parkinson's Disease | StressMarq
Frontiers | Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson's Disease | Neuroscience
α-Synuclein Aggregates Increase the Conductance of Substantia Nigra Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor Glibenclamide | eNeuro
Interactions between iron and α-synuclein pathology in Parkinson's disease - ScienceDirect
RCSB PDB - 3Q27: Cyrstal structure of human alpha-synuclein (32-57) fused to maltose binding protein (MBP)
